Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Olema Pharmaceuticals Inc...

    NASDAQ: OLMA · Real-Time Price · USD
    4.03
    -0.16 (-3.82%)
    At close: Jun 17, 2025, 3:42 PM

    Olema Pharmaceuticals Statistics

    Share Statistics

    Olema Pharmaceuticals has 68.42M shares outstanding. The number of shares has increased by 22.17% in one year.

    Shares Outstanding

    n/a
    		 68.42M

    Shares Change (YoY)

    n/a
    		 22.17%

    Shares Change (QoQ)

    n/a
    		 19.26%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 52.12M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,745

    FTD / Avg. Volume

    n/a
    		 0.19%

    Short Selling Information

    The latest short interest is 6.3M, so 9.21% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 6.3M

    Short % of Shares Out

    n/a
    		 9.21%

    Short % of Float

    n/a
    		 10.13%

    Short Ratio (days to cover)

    n/a
    		 12.39

    Valuation Ratios

    The PE ratio is -2.65 and the forward PE ratio is -1.91. Olema Pharmaceuticals's PEG ratio is -0.94.

    PE Ratio

    n/a
    		 -2.65

    Forward PE

    n/a
    		 -1.91

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.9

    PB Ratio

    n/a
    		 0.84

    P/FCF Ratio

    n/a
    		 -3.28

    PEG Ratio

    n/a
    		 -0.94
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Olema Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 10.5, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 10.5

    Quick Ratio

    n/a
    		 10.5

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,348,687.5

    Employee Count

    n/a
    		 96

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -64.7% in the last 52 weeks. The beta is 2.01, so Olema Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.01

    52-Week Price Change

    n/a
    		 -64.7%

    50-Day Moving Average

    n/a
    		 4.54

    200-Day Moving Average

    n/a
    		 7.3

    Relative Strength Index (RSI)

    n/a
    		 42.54

    Average Volume (20 Days)

    n/a
    		 937,866

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -142.26M

    Net Income

    n/a
    		 -129.47M

    EBITDA

    n/a
    		 -129.08M

    EBIT

    n/a
    		 -129.47M

    Earnings Per Share (EPS)

    n/a
    		 -2.2
    Full Income Statement

    Balance Sheet

    The company has 139.48M in cash and 1.43M in debt, giving a net cash position of 138.05M.

    Cash & Cash Equivalents

    n/a
    		 139.48M

    Total Debt

    n/a
    		 1.43M

    Net Cash

    n/a
    		 138.05M

    Retained Earnings

    n/a
    		 -435.11M

    Total Assets

    n/a
    		 409.64M

    Working Capital

    n/a
    		 370.6M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -104.35M and capital expenditures -159K, giving a free cash flow of -104.51M.

    Operating Cash Flow

    n/a
    		 -104.35M

    Capital Expenditures

    n/a
    		 -159K

    Free Cash Flow

    n/a
    		 -104.51M

    FCF Per Share

    n/a
    		 -1.78
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    OLMA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for OLMA is $25, which is 496.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $25

    Price Target Difference

    n/a
    		 496.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 6.67

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist